Desmoid tumor of chest wall
ICD-10 D48.111 is a billable code used to indicate a diagnosis of desmoid tumor of chest wall.
Desmoid tumors, also known as aggressive fibromatosis, are benign neoplasms that arise from the connective tissue and are characterized by their infiltrative growth pattern. The desmoid tumor of the chest wall specifically refers to tumors located in the soft tissues of the thoracic region. Although these tumors are not malignant, they can exhibit aggressive behavior, leading to local invasion and recurrence. Clinically, patients may present with a palpable mass, pain, or discomfort in the chest area. Imaging studies, such as MRI or CT scans, are often utilized to assess the extent of the tumor and its relationship to surrounding structures. Surgical excision is the primary treatment; however, due to the tumor's tendency to recur, close surveillance is necessary post-operatively. The uncertain behavior of desmoid tumors necessitates careful monitoring, as they can progress and cause significant morbidity despite being classified as benign. The management of desmoid tumors often involves a multidisciplinary approach, including surgical, medical, and sometimes radiation therapy, depending on the tumor's size, location, and symptoms.
Detailed pathology reports, imaging studies, and treatment plans must be documented.
Patients presenting with a palpable mass in the chest wall, requiring imaging and potential surgical intervention.
Ensure accurate staging and follow-up documentation to monitor for recurrence.
Operative reports detailing the surgical approach, margins, and any complications.
Surgical excision of desmoid tumors with post-operative follow-up.
Document the rationale for surgical intervention and any adjuvant therapies considered.
Used when a desmoid tumor requires partial mastectomy due to its location.
Operative report detailing the procedure and findings.
Oncology and surgical documentation must align for accurate coding.
A desmoid tumor is a benign but aggressive neoplasm that arises from connective tissue and can invade surrounding structures. It is characterized by its infiltrative growth and potential for recurrence.
Treatment typically involves surgical excision, but due to the risk of recurrence, ongoing surveillance is essential. In some cases, systemic therapy may be considered.
